Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-112,548
Closed -$8.51M 67
2026
Q1
$8.51M Buy
+112,548
New +$8.46M 5.99% 4

Trium Capital's HOLX Position: Q2 2026 in Review

Trium Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 112,548 shares — an estimated $8.51M sold.

Trium Capital first reported a position in HOLX in Q1 2026 and held it in 1 quarter. The position peaked at $8.51M in Q1 2026. 0 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Trium Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Trium Capital sold 112,548 Hologic shares in Q2 2026, an estimated $8.51M.
  • Trium Capital first reported a position in Hologic in Q1 2026 and held it in 1 quarter.
  • Trium Capital's Hologic position peaked at $8.51M in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Trium Capital's 13F filing for Q2 2026, filed 16 Jul 2026.